Masthead Security Wireless Internet Cable Telephone email
ADVERTISEMENT
Today's Health Headlines
(Reuters) - Celgene Corp said it would invest about $1 billion in Juno Therapeutics Inc to partner in the development and marketing of immunotherapies for the treatment of cancer and autoimmune diseases.










(Reuters Health) - State-run insurance programs for the poor may be putting up illegal barriers that prevent people with hepatitis C from getting a new treatment, a new study suggests.

SACRAMENTO, Calif. (Reuters) - California lawmakers on Monday sent Governor Jerry Brown a bill to substantially limit vaccine exemptions for school children in the most populous U.S. state, following last year's measles outbreak at Disneyland that sickened more than 100 people.










(Reuters Health) - Using data from two long-term studies of women and men, researchers found a potential link between citrus consumption and malignant melanoma of the skin.










(Reuters) - The Food and Drug Administration was sued by two advocacy groups seeking to force the faster disclosure of clinical trial data that helped Gilead Sciences Inc win approval for two blockbuster hepatitis C drugs.

Few people heading toward diabetes know it
Mon, 29 Jun 2015 18:39:24 GMT
(Reuters Health) - Only about one in eight people with so-called pre-diabetes, often a precursor to full-blown disease, know they have a problem, a U.S. study found.










(Reuters Health) - Phone-based surveys show that nearly four of every 10 kids and teens in the U.S. were exposed to violence or abuse over the previous year, researchers have found.

(Reuters) - Vitae Pharmaceuticals Inc said its diabetes drug failed to significantly reduce blood sugar levels of patients when used as an add-on therapy, raising questions about the drug's potential.










NEW YORK (Reuters) - Virtual reality is making inroads into group fitness classes and personal training sessions and promises to get more immersive as the technology advances, according to fitness experts.

(Reuters) - Egalet Corp said data showed its experimental painkiller was less likely to be abused than a form of morphine already being sold.

ADVERTISEMENT
Log Into Your sktc.net Account
MY ACCOUNT
MORE HEADLINES
thumbnail
ATLANTA (Reuters) - A plane carrying a second American aid ......
thumbnail
LONDON (Reuters) - Expectations are building for a new ......
BANGKOK (Reuters) - Authorities in Thailand are to inspect ......
NEW YORK (Reuters Health) - Under the Affordable Care Act, ......
Authorities have been monitoring anyone who came into ......
thumbnail
TOKYO (Reuters) - Japan's biggest drugmaker Takeda ......
thumbnail
FREETOWN/MONROVIA (Reuters) - Hundreds of troops deployed ......
NEW YORK (Reuters Health) - Hepatitis C may become a ......
thumbnail
WASHINGTON (Reuters) - International development banks on ......
NEW YORK (Reuters Health) - Physical therapy and steroid ......
ADVERTISEMENT
loading